Balance Sheet Data
Celldex Therapeutics, Inc. (CLDX)
$35.24
+0.46 (+1.32%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 94.02 | 64.38 | 194.42 | 408.25 | 304.95 | 114.58 | 102.68 | 92.01 | 82.46 | 73.89 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 3.16 | 1.01 | 1.80 | 0.17 | 0.35 | 0.44 | 0.39 | 0.35 | 0.32 | 0.28 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.07 | 1.17 | 1.05 | 1.23 | 3.34 | 0.96 | 0.86 | 0.77 | 0.69 | 0.62 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.81 | -0.73 | -1.55 | -1.25 | -1.83 | -0.65 | -0.58 | -0.52 | -0.47 | -0.42 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.